Clinical Trial Update: Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis [Phase 3]

View source ↗

Summary

This clinical trial update describes ongoing Phase 3 efficacy and safety studies of Frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Frexalimab (SAR441344)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 3 | Status: RECRUITING